NCT01581307: Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets |
|
|
| Completed | 2 | 9 | US | FOLFOX7 (Folinic acid, 5-Fluorouracil, and Oxaliplatin), Leucovorin, LV, FOL, OX, 5-Fluorouracil (5-FU), FOLFOX, ELOXATIN, TheraSpheres, radiotherapy, radioembolization | H. Lee Moffitt Cancer Center and Research Institute, BTG International Inc. | Liver Cancer, Pancreatic Cancer | 02/16 | 03/16 | | |